It looks like you have an older browser that is not supported by this site. Please click here to update.

BinaxNOW COVID-19 Cards – REDCaps Reporting Required - IHCA

It looks like you have an older browser that is not supported by this site. Please click here to update.

Article Open to All

BinaxNOW COVID-19 Cards – REDCaps Reporting Required

Posted Sep 16, 20202 min Read

Back

By September 18, 2020, the nursing facilities and assisted living communities listed on this spreadsheet are expected to receive Abbott BinaxNOW COVID-19 Ag Cards, a Point of Care (POC) SARS-CoV-2 diagnostic test.  More about the BinaxNOW COVID-19 cards can be found here.

Long-term care providers located in yellow and red counties were prioritized for this shipment.  These shipments will arrive directly from the manufacturer and will include 40 cards and 40 nasal swaps.  The shipments are expected to continue through December 20, 2020, but the shipment schedule beyond this week is unknown.  As we learn more about future shipment schedules, we will keep you updated.

Please note that the invoices sent out from Abbott were a mistake and do NOT need to be paid.

Importantly, all long-term care facilities that receive and utilize the BinaxNOW COVID-19 Cards must report all negative and positive results from these POC tests to the Indiana State Department of Health (ISDH) through the specific REDCaps Survey for POC test results, which can be found here.  The entirety of the ISDH’s reporting guidance for POC tests can be found here.

Once you have landed on the REDCaps Survey for POC test results, facilities should select their facility name from the drop-down list.  If your facility name is not included in the list, please email Kelly White at KeWhite@isdh.in.gov.

Please note, all long-term care facilities should continue to report positive COVID-19 cases and deaths confirmed via a PCR test within 24 hours of knowledge to the following REDCap Survey.

Finally, as a reminder, any residents and staff who test positive via a POC test should be administered a PCR test as a follow-up, which should be reported accordingly. For ISDH’s recommended protocol on antigen testing, please click here.